Syringe Access
Testimony: New Jersey should invest generational opioid settlement funds in public health approach to drug use
Written Testimony to the New Jersey Opioid Settlement Advisory Council Dear Members of the New Jersey Opioid Settlement Advisory Council, It’s widely recognized that we won’t be able to arrest our way out of the overdose crisis and that drug use is a public health issue, not a criminal one. With opioid settlement funds, New … Read more
Checklist: What To Consider When Starting A Harm Reduction Service
This checklist is a guide of elements to consider when reviewing the application for authorization and designing your syringe access program.
Drug deaths rise, but NJ’s needle-exchange sites stalled
By Lilo H. Stainton, NJ Spotlight News
More safe syringe sites needed to reduce infections from injecting drugs, study says
By Dana DiFilippo, New Jersey Monitor
Drug use infections add to death toll from opioid use
By Lindy Washburn, NorthJersey.com
New Report – $1.0 billion in annual healthcare costs from preventable injection-related infections in New Jersey
Without access to harm reduction supplies, New Jerseyans who inject drugs are at risk of infection, hospitalization, and preventable death, according to a new report released today by New Jersey Harm Reduction Coalition (NJHRC). The report, Preventable Harms: Injection Drug-Use Related Infections in New Jersey, reviews data from the Healthcare Cost and Utilization Project and … Read more